Lidocaine kills cancer cells by activating bitter taste receptor, preclinical study shows

Lidocaine—often used as a numbing agent for outpatient medical procedures—activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

Leave A Comment

Your email address will not be published. Required fields are marked *